TC
TMDX icon

Truvestments Capital’s Transmedics TMDX Stock Holding History

Truvestments Capital’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-57
Closed -$5.67K – 1285
2026
Q1 		$5.67K Hold
57
– – ﹤0.01% 862
2025
Q4 		$6.93K Hold
57
– – ﹤0.01% 749
2025
Q3 		$6.39K Hold
57
– – ﹤0.01% 775
2025
Q2 		$7.64K Hold
57
– – ﹤0.01% 684
2025
Q1 		$3.83K Hold
57
– – ﹤0.01% 782
2024
Q4 		$3.55K Hold
57
– – ﹤0.01% 748
2024
Q3 		$8.95K Buy
+57
New +$8.78K ﹤0.01% 598
2024
Q2 		– Sell
-90
Closed -$6.66K – 646
2024
Q1 		$6.66K Hold
90
– – ﹤0.01% 527
2023
Q4 		$7.1K Hold
90
– – ﹤0.01% 548
2023
Q3 		$4.93K Hold
90
– – ﹤0.01% 515
2023
Q2 		$7.56K Hold
90
– – ﹤0.01% 479
2023
Q1 		$6.82K Buy
+90
New +$6.22K ﹤0.01% 473

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Truvestments Capital's TMDX Position: Q2 2026 in Review

Truvestments Capital sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 57 shares — an estimated $5.67K sold.

Truvestments Capital first reported a position in TMDX in Q1 2023 and held it in 12 quarters. The position peaked at $8.95K in Q3 2024. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Truvestments Capital reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Truvestments Capital sold 57 Transmedics shares in Q2 2026, an estimated $5.67K.
  • Truvestments Capital first reported a position in Transmedics in Q1 2023 and held it in 12 quarters.
  • Truvestments Capital's Transmedics position peaked at $8.95K in Q3 2024.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.